BCTX - Briacell Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCTX is currently covered by 1 analysts with an average price target of $116.25. This is a potential upside of $109 (1503.45%) from yesterday's end of day stock price of $7.25.

Briacell Therapeutics Corp's activity chart (see below) currently has 12 price targets and 14 ratings on display. The stock rating distribution of BCTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 185 days.

Highest price target for BCTX is $54, Lowest price target is $41.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 22-Apr-2025. First documented stock forecast 14-Feb-2022.

Best performing analysts who are covering BCTX - Briacell Therapeutics Corp:

Emily Bodnar

Currently out of the existing stock ratings of BCTX, 2 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 14-Feb-2022

$150

8 months 19 days ago
(22-Apr-2025)

10/12 (83.33%)

$109 (265.85%)

185

Show more analysts

Please expand the browser size to see the chart

What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?

On average it took 185 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on BCTX (Briacell Therapeutics Corp) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar works at HC WAINWRIGHT and has 16 price targets and 16 ratings on BCTX

Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?

Emily Bodnar with highest potential upside - $0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?